![Dennis Turner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Dennis Turner.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.
10
| Extinct | Miscellaneous Commercial Services | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Dennis Turner a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NOVACYT | Medical Specialties | General Counsel | |
Walter Siegenthaler Gesellschaft | Director/Board Member | ||
COVESTRO AG | Chemicals: Specialty | Chairman | |
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Chairman | |
Ludwig Heilmeyer Society | Director/Board Member | ||
German Asia Pacific Business Association | Corporate Officer/Principal | ||
Paul Ehrlich-Foundation | Chairman | ||
German Chemical Industry Fund | Director/Board Member | ||
Conseil Européen de l'industrie Chimique - European Chemical
![]() Conseil Européen de l'industrie Chimique - European Chemical Wholesale DistributorsDistribution Services Conseil Européen de l'industrie Chimique, also known as the European Chemical Industry Council (Cefic), is a non-profit organization that represents large, medium, and small chemical companies across Europe. The non-profit company was founded in 1972 and is based in Brussels, Belgium, with subsidiaries in Belgium. Cefic is committed to the UN sustainability agenda and has developed a unique roadmap, called the Transition Pathway, to guide the European chemicals industry through the massive transformation needed to meet the EU Green Deal goals. The Transition Pathway lays out more than 200 actions for the EU institutions, Member State governments, and industry to build the business case for investing in sustainability. Cefic provides clarity, predictability, and direction to guide the industry through the transition. | Wholesale Distributors | Corporate Officer/Principal | |
Bayer Real Estate GmbH
![]() Bayer Real Estate GmbH Real Estate DevelopmentFinance Founded in 1934, Bayer Real Estate GmbH is a subsidiary of Bayer AG that engages in the management of land, buildings, and apartments. The company is based in Leverkusen, Germany. | Real Estate Development | Chairman | |
Bundesverband der Deutschen Industrie e.V.
![]() Bundesverband der Deutschen Industrie e.V. Miscellaneous Commercial ServicesCommercial Services Bundesverband der Deutschen Industrie e.V. provides information on the German industry, economy, and economic policies. The private company is based in Berlin, Germany. The German company organizes events that bring together business, politics, science, and civil society for discussions, whether virtually, in-person, or hybrid. The company was founded by Gerhard Schempp. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Hohenheim | College/University | Corporate Officer/Principal | |
Robert Koch Stiftung eV | Chief Executive Officer | ||
Transine Therapeutics Ltd.
![]() Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
EVOTEC SE | Pharmaceuticals: Major | Chairman | |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bayer Yakuhin Ltd.
![]() Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Bayer Yakuhin Ltd. is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan. | Pharmaceuticals: Major | President | |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
University of London | College/University | Doctorate Degree | |
Imperial College London | College/University | Doctorate Degree | |
Takeda Europe Research & Development Centre
![]() Takeda Europe Research & Development Centre Miscellaneous Commercial ServicesCommercial Services Takeda Europe Research & Development Centre is a British company that specializes in Biological Research. The private company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ark Therapeutics Oy | Corporate Officer/Principal | ||
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Valo Therapeutics Ltd. | Chief Executive Officer | ||
Bayer Innovation GmbH
![]() Bayer Innovation GmbH Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Bayer Innovation GmbH conducts creative pharmaceutical research. The company is based in Dusseldorf, Germany. The CEO of the German company is Detlef Wollweber. | Miscellaneous Commercial Services | Chairman | |
AstraZeneca Canada, Inc.
![]() AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Patheon France SAS
![]() Patheon France SAS Pharmaceuticals: MajorHealth Technology Patheon France SAS provides drug development and manufacturing services. The company is headquartered in Bourgoin-Jallieu, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Chartered Institute of Management Accountants
![]() The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Other Consumer Services | Corporate Officer/Principal | |
VOLITIONRX LIMITED | Medical Specialties | General Counsel | |
ELEMENTIS PLC | Chemicals: Specialty | Director/Board Member | |
B.Z.W. Ltd. | Corporate Officer/Principal | ||
Conservation Education & Research Trust
![]() Conservation Education & Research Trust Miscellaneous Commercial ServicesCommercial Services Conservation Education & Research Trust is an organization that conducts research on environmental challenges such as biodiversity loss, freshwater pollution, and soil health. The non-profit company is based in Oxford, UK. The British company engages volunteers and corporate partners to contribute to a sustainable future through citizen science. The CEO of the company is Steve Gray. | Miscellaneous Commercial Services | Director/Board Member | |
Smith Square Partners LLP
![]() Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
HELIOS UNDERWRITING PLC | Insurance Brokers/Services | Director/Board Member | |
Credit Suisse (Europe) Ltd.
![]() Credit Suisse (Europe) Ltd. Investment Banks/BrokersFinance Part of UBS Group AG, Credit Suisse (Europe) Ltd. is a financial institution that offers private and investment banking, as well as asset management services. | Investment Banks/Brokers | Corporate Officer/Principal | |
Cable & Wireless Ltd.
![]() Cable & Wireless Ltd. Major TelecommunicationsCommunications Cable & Wireless Ltd. operates as a telecommunications company. The company was founded in 1929 and is headquartered in London, the United Kingdom. | Major Telecommunications | Director of Finance/CFO | |
PCCW LIMITED | Major Telecommunications | Director of Finance/CFO | |
SMARTONE TELECOMMUNICATIONS HOLDINGS LIMITED | Wireless Telecommunications | Director/Board Member | |
ADECCO GROUP AG | Personnel Services | Director/Board Member | |
Linear Diagnostics Ltd.
![]() Linear Diagnostics Ltd. Medical SpecialtiesHealth Technology Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
Alemania | 21 |
Reino Unido | 17 |
Estados Unidos | 5 |
Hong-Kong | 4 |
Francia | 3 |
Sectorial
Health Technology | 15 |
Commercial Services | 8 |
Finance | 7 |
Consumer Services | 6 |
Communications | 5 |
Operativa
Director/Board Member | 26 |
Corporate Officer/Principal | 25 |
Chairman | 8 |
Independent Dir/Board Member | 7 |
Chief Tech/Sci/R&D Officer | 6 |
Las relaciones más conectadas
Insiders | |
---|---|
Wolfgang Plischke | 21 |
David Prince | 13 |
Alan Keith Boyd | 12 |
Andrew Christie | 9 |
Paul Grant Higham | 8 |
David Eckland | 6 |
Nick Plummer | 4 |
Robert Shaw | 2 |
Edward Bliss | 1 |
David Bowyer | 1 |
- Bolsa de valores
- Insiders
- Dennis Turner
- Conexiones Empresas